Invivyd, Inc. (IVVD)
0.9963
+0.03
(+3.30%)
USD |
NASDAQ |
Aug 31, 09:55
Invivyd Market Cap : 293.66M for Aug. 31, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| August 28, 2026 | 284.29M |
| August 27, 2026 | 265.31M |
| August 26, 2026 | 265.78M |
| August 25, 2026 | 276.69M |
| August 24, 2026 | 277.81M |
| August 21, 2026 | 293.72M |
| August 20, 2026 | 280.25M |
| August 19, 2026 | 282.82M |
| August 18, 2026 | 255.88M |
| August 17, 2026 | 218.27M |
| August 14, 2026 | 212.49M |
| August 13, 2026 | 202.11M |
| August 12, 2026 | 215.76M |
| August 11, 2026 | 202.64M |
| August 10, 2026 | 190.36M |
| August 07, 2026 | 209.27M |
| August 06, 2026 | 186.37M |
| August 05, 2026 | 170.93M |
| August 04, 2026 | 162.10M |
| August 03, 2026 | 155.99M |
| July 31, 2026 | 151.30M |
| July 30, 2026 | 164.48M |
| July 29, 2026 | 153.56M |
| July 28, 2026 | 167.79M |
| July 27, 2026 | 172.48M |
| Date | Value |
|---|---|
| July 24, 2026 | 172.91M |
| July 23, 2026 | 172.28M |
| July 22, 2026 | 175.37M |
| July 21, 2026 | 192.79M |
| July 20, 2026 | 193.81M |
| July 17, 2026 | 209.98M |
| July 16, 2026 | 222.82M |
| July 15, 2026 | 231.05M |
| July 14, 2026 | 226.47M |
| July 13, 2026 | 222.71M |
| July 10, 2026 | 221.55M |
| July 09, 2026 | 227.29M |
| July 08, 2026 | 234.73M |
| July 07, 2026 | 266.34M |
| July 06, 2026 | 235.86M |
| July 02, 2026 | 252.77M |
| July 01, 2026 | 241.63M |
| June 30, 2026 | 246.72M |
| June 29, 2026 | 266.88M |
| June 26, 2026 | 252.18M |
| June 25, 2026 | 248.53M |
| June 24, 2026 | 264.08M |
| June 23, 2026 | 264.31M |
| June 22, 2026 | 258.60M |
| June 18, 2026 | 274.29M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Agenus, Inc. | 325.58M |
| Amgen, Inc. | 231.74B |
| Anika Therapeutics, Inc. | 277.16M |
| BioCryst Pharmaceuticals, Inc. | 2.422B |
| Imunon, Inc. | 7.325M |
Market Cap Related Metrics
| PS Ratio | 4.619 |
| Price to Book Value | 1.622 |
| Price | 0.9963 |
| Earnings Yield | -37.44% |